A Genome-Wide Significant Linkage for Severe Depression on Chromosome 3: The Depression Network Study
- Gerome Breen,
Ph.D. , - Bradley Todd Webb,
Ph.D. , - Amy W. Butler,
Ph.D. , - Edwin J.C.G. van den Oord,
Ph.D. , - Federica Tozzi,
Ph.D. , - Nick Craddock,
F.R.C.Psych., Ph.D., F.Med.Sci. , - Mike Gill,
F.R.C.Psych., Ph.D. , - Ania Korszun,
Ph.D., M.D., M.R.C.Psych. , - Wolfgang Maier,
M.D. , - Lefkos Middleton,
M.D., F.R.C.Psych. , - Ole Mors,
M.D., Ph.D. , - Michael J. Owen,
F.R.C.Psych., Ph.D., F.Med.Sci. , - Sarah Cohen-Woods,
Ph.D. , - Julia Perry,
Ph.D. , - Nicholas W. Galwey,
Ph.D. , - Ruchi Upmanyu,
Ph.D. , - Ian Craig,
Ph.D. , - Cathryn M. Lewis,
Ph.D. , - Mandy Ng,
Ph.D. , - Shyama Brewster,
B.Sc. , - Martin Preisig,
M.D., M.P.H. , - Marcella Rietschel,
M.D. , - Lisa Jones,
Ph.D. , - Jo Knight,
Ph.D. , - John Rice,
Ph.D. , - Pierandrea Muglia,
M.D. , - Anne E. Farmer,
M.D., F.R.C.Psych. , and - Peter McGuffin,
F.R.C.P., F.R.C.Psych., Ph.D., F.Med.Sci.
From the Medical Research Council Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London; the National Institute for Health Research Biomedical Research Centre at South London and Maudsley National Health Service Trust and Institute of Psychiatry, King's College London, London; the Virginia Institute for Psychiatric and Behavioral Genetics of Virginia Commonwealth University, Richmond, Va.; the Center for Biomarker Research and Personalized Medicine, Virginia Commonwealth University, Richmond, Va.; the Department of Pharmacy, Virginia Commonwealth University, Richmond, Va.; Medical Genetics, GlaxoSmithKline, Verona, Italy, and Greenford, United Kingdom; the Medical Research Council Centre for Neuropsychiatric Genetics and Genomics and Neuroscience and Mental Health Research Institute, Cardiff University, Cardiff, United Kingdom; the Department of Psychiatry, Trinity Centre for Health Sciences, Dublin; Barts and the London School of Medicine and Dentistry, London; the Department of Psychiatry, University of Bonn, Bonn, Germany; the Division of Neuroscience and Mental Health, Faculty of Medicine, Imperial College, London; the Max Planck Institute of Psychiatry, Munich, Germany; the Center for Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; the Department of Adult Psychiatry, University Hospital Center and University of Lausanne, Lausanne, Switzerland; the Central Institute of Mental Health, Mannheim, Germany; the Department of Psychiatry, University of Birmingham, Birmingham, United Kingdom; the Department of Medical and Molecular Genetics, King's College London, London; the National Institute for Health Research Comprehensive Biomedical Research Centre at Guy's and St. Thomas' National Health Service Foundation Trust and King's College London, London; the Department of Psychiatry, Washington University, St Louis; NeuroSearch A/S; and the Department of Psychiatry, University of Toronto, Toronto.
From the Medical Research Council Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London; the National Institute for Health Research Biomedical Research Centre at South London and Maudsley National Health Service Trust and Institute of Psychiatry, King's College London, London; the Virginia Institute for Psychiatric and Behavioral Genetics of Virginia Commonwealth University, Richmond, Va.; the Center for Biomarker Research and Personalized Medicine, Virginia Commonwealth University, Richmond, Va.; the Department of Pharmacy, Virginia Commonwealth University, Richmond, Va.; Medical Genetics, GlaxoSmithKline, Verona, Italy, and Greenford, United Kingdom; the Medical Research Council Centre for Neuropsychiatric Genetics and Genomics and Neuroscience and Mental Health Research Institute, Cardiff University, Cardiff, United Kingdom; the Department of Psychiatry, Trinity Centre for Health Sciences, Dublin; Barts and the London School of Medicine and Dentistry, London; the Department of Psychiatry, University of Bonn, Bonn, Germany; the Division of Neuroscience and Mental Health, Faculty of Medicine, Imperial College, London; the Max Planck Institute of Psychiatry, Munich, Germany; the Center for Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; the Department of Adult Psychiatry, University Hospital Center and University of Lausanne, Lausanne, Switzerland; the Central Institute of Mental Health, Mannheim, Germany; the Department of Psychiatry, University of Birmingham, Birmingham, United Kingdom; the Department of Medical and Molecular Genetics, King's College London, London; the National Institute for Health Research Comprehensive Biomedical Research Centre at Guy's and St. Thomas' National Health Service Foundation Trust and King's College London, London; the Department of Psychiatry, Washington University, St Louis; NeuroSearch A/S; and the Department of Psychiatry, University of Toronto, Toronto.
From the Medical Research Council Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London; the National Institute for Health Research Biomedical Research Centre at South London and Maudsley National Health Service Trust and Institute of Psychiatry, King's College London, London; the Virginia Institute for Psychiatric and Behavioral Genetics of Virginia Commonwealth University, Richmond, Va.; the Center for Biomarker Research and Personalized Medicine, Virginia Commonwealth University, Richmond, Va.; the Department of Pharmacy, Virginia Commonwealth University, Richmond, Va.; Medical Genetics, GlaxoSmithKline, Verona, Italy, and Greenford, United Kingdom; the Medical Research Council Centre for Neuropsychiatric Genetics and Genomics and Neuroscience and Mental Health Research Institute, Cardiff University, Cardiff, United Kingdom; the Department of Psychiatry, Trinity Centre for Health Sciences, Dublin; Barts and the London School of Medicine and Dentistry, London; the Department of Psychiatry, University of Bonn, Bonn, Germany; the Division of Neuroscience and Mental Health, Faculty of Medicine, Imperial College, London; the Max Planck Institute of Psychiatry, Munich, Germany; the Center for Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; the Department of Adult Psychiatry, University Hospital Center and University of Lausanne, Lausanne, Switzerland; the Central Institute of Mental Health, Mannheim, Germany; the Department of Psychiatry, University of Birmingham, Birmingham, United Kingdom; the Department of Medical and Molecular Genetics, King's College London, London; the National Institute for Health Research Comprehensive Biomedical Research Centre at Guy's and St. Thomas' National Health Service Foundation Trust and King's College London, London; the Department of Psychiatry, Washington University, St Louis; NeuroSearch A/S; and the Department of Psychiatry, University of Toronto, Toronto.
From the Medical Research Council Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London; the National Institute for Health Research Biomedical Research Centre at South London and Maudsley National Health Service Trust and Institute of Psychiatry, King's College London, London; the Virginia Institute for Psychiatric and Behavioral Genetics of Virginia Commonwealth University, Richmond, Va.; the Center for Biomarker Research and Personalized Medicine, Virginia Commonwealth University, Richmond, Va.; the Department of Pharmacy, Virginia Commonwealth University, Richmond, Va.; Medical Genetics, GlaxoSmithKline, Verona, Italy, and Greenford, United Kingdom; the Medical Research Council Centre for Neuropsychiatric Genetics and Genomics and Neuroscience and Mental Health Research Institute, Cardiff University, Cardiff, United Kingdom; the Department of Psychiatry, Trinity Centre for Health Sciences, Dublin; Barts and the London School of Medicine and Dentistry, London; the Department of Psychiatry, University of Bonn, Bonn, Germany; the Division of Neuroscience and Mental Health, Faculty of Medicine, Imperial College, London; the Max Planck Institute of Psychiatry, Munich, Germany; the Center for Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; the Department of Adult Psychiatry, University Hospital Center and University of Lausanne, Lausanne, Switzerland; the Central Institute of Mental Health, Mannheim, Germany; the Department of Psychiatry, University of Birmingham, Birmingham, United Kingdom; the Department of Medical and Molecular Genetics, King's College London, London; the National Institute for Health Research Comprehensive Biomedical Research Centre at Guy's and St. Thomas' National Health Service Foundation Trust and King's College London, London; the Department of Psychiatry, Washington University, St Louis; NeuroSearch A/S; and the Department of Psychiatry, University of Toronto, Toronto.
From the Medical Research Council Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London; the National Institute for Health Research Biomedical Research Centre at South London and Maudsley National Health Service Trust and Institute of Psychiatry, King's College London, London; the Virginia Institute for Psychiatric and Behavioral Genetics of Virginia Commonwealth University, Richmond, Va.; the Center for Biomarker Research and Personalized Medicine, Virginia Commonwealth University, Richmond, Va.; the Department of Pharmacy, Virginia Commonwealth University, Richmond, Va.; Medical Genetics, GlaxoSmithKline, Verona, Italy, and Greenford, United Kingdom; the Medical Research Council Centre for Neuropsychiatric Genetics and Genomics and Neuroscience and Mental Health Research Institute, Cardiff University, Cardiff, United Kingdom; the Department of Psychiatry, Trinity Centre for Health Sciences, Dublin; Barts and the London School of Medicine and Dentistry, London; the Department of Psychiatry, University of Bonn, Bonn, Germany; the Division of Neuroscience and Mental Health, Faculty of Medicine, Imperial College, London; the Max Planck Institute of Psychiatry, Munich, Germany; the Center for Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; the Department of Adult Psychiatry, University Hospital Center and University of Lausanne, Lausanne, Switzerland; the Central Institute of Mental Health, Mannheim, Germany; the Department of Psychiatry, University of Birmingham, Birmingham, United Kingdom; the Department of Medical and Molecular Genetics, King's College London, London; the National Institute for Health Research Comprehensive Biomedical Research Centre at Guy's and St. Thomas' National Health Service Foundation Trust and King's College London, London; the Department of Psychiatry, Washington University, St Louis; NeuroSearch A/S; and the Department of Psychiatry, University of Toronto, Toronto.
From the Medical Research Council Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London; the National Institute for Health Research Biomedical Research Centre at South London and Maudsley National Health Service Trust and Institute of Psychiatry, King's College London, London; the Virginia Institute for Psychiatric and Behavioral Genetics of Virginia Commonwealth University, Richmond, Va.; the Center for Biomarker Research and Personalized Medicine, Virginia Commonwealth University, Richmond, Va.; the Department of Pharmacy, Virginia Commonwealth University, Richmond, Va.; Medical Genetics, GlaxoSmithKline, Verona, Italy, and Greenford, United Kingdom; the Medical Research Council Centre for Neuropsychiatric Genetics and Genomics and Neuroscience and Mental Health Research Institute, Cardiff University, Cardiff, United Kingdom; the Department of Psychiatry, Trinity Centre for Health Sciences, Dublin; Barts and the London School of Medicine and Dentistry, London; the Department of Psychiatry, University of Bonn, Bonn, Germany; the Division of Neuroscience and Mental Health, Faculty of Medicine, Imperial College, London; the Max Planck Institute of Psychiatry, Munich, Germany; the Center for Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; the Department of Adult Psychiatry, University Hospital Center and University of Lausanne, Lausanne, Switzerland; the Central Institute of Mental Health, Mannheim, Germany; the Department of Psychiatry, University of Birmingham, Birmingham, United Kingdom; the Department of Medical and Molecular Genetics, King's College London, London; the National Institute for Health Research Comprehensive Biomedical Research Centre at Guy's and St. Thomas' National Health Service Foundation Trust and King's College London, London; the Department of Psychiatry, Washington University, St Louis; NeuroSearch A/S; and the Department of Psychiatry, University of Toronto, Toronto.
From the Medical Research Council Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London; the National Institute for Health Research Biomedical Research Centre at South London and Maudsley National Health Service Trust and Institute of Psychiatry, King's College London, London; the Virginia Institute for Psychiatric and Behavioral Genetics of Virginia Commonwealth University, Richmond, Va.; the Center for Biomarker Research and Personalized Medicine, Virginia Commonwealth University, Richmond, Va.; the Department of Pharmacy, Virginia Commonwealth University, Richmond, Va.; Medical Genetics, GlaxoSmithKline, Verona, Italy, and Greenford, United Kingdom; the Medical Research Council Centre for Neuropsychiatric Genetics and Genomics and Neuroscience and Mental Health Research Institute, Cardiff University, Cardiff, United Kingdom; the Department of Psychiatry, Trinity Centre for Health Sciences, Dublin; Barts and the London School of Medicine and Dentistry, London; the Department of Psychiatry, University of Bonn, Bonn, Germany; the Division of Neuroscience and Mental Health, Faculty of Medicine, Imperial College, London; the Max Planck Institute of Psychiatry, Munich, Germany; the Center for Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; the Department of Adult Psychiatry, University Hospital Center and University of Lausanne, Lausanne, Switzerland; the Central Institute of Mental Health, Mannheim, Germany; the Department of Psychiatry, University of Birmingham, Birmingham, United Kingdom; the Department of Medical and Molecular Genetics, King's College London, London; the National Institute for Health Research Comprehensive Biomedical Research Centre at Guy's and St. Thomas' National Health Service Foundation Trust and King's College London, London; the Department of Psychiatry, Washington University, St Louis; NeuroSearch A/S; and the Department of Psychiatry, University of Toronto, Toronto.
From the Medical Research Council Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London; the National Institute for Health Research Biomedical Research Centre at South London and Maudsley National Health Service Trust and Institute of Psychiatry, King's College London, London; the Virginia Institute for Psychiatric and Behavioral Genetics of Virginia Commonwealth University, Richmond, Va.; the Center for Biomarker Research and Personalized Medicine, Virginia Commonwealth University, Richmond, Va.; the Department of Pharmacy, Virginia Commonwealth University, Richmond, Va.; Medical Genetics, GlaxoSmithKline, Verona, Italy, and Greenford, United Kingdom; the Medical Research Council Centre for Neuropsychiatric Genetics and Genomics and Neuroscience and Mental Health Research Institute, Cardiff University, Cardiff, United Kingdom; the Department of Psychiatry, Trinity Centre for Health Sciences, Dublin; Barts and the London School of Medicine and Dentistry, London; the Department of Psychiatry, University of Bonn, Bonn, Germany; the Division of Neuroscience and Mental Health, Faculty of Medicine, Imperial College, London; the Max Planck Institute of Psychiatry, Munich, Germany; the Center for Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; the Department of Adult Psychiatry, University Hospital Center and University of Lausanne, Lausanne, Switzerland; the Central Institute of Mental Health, Mannheim, Germany; the Department of Psychiatry, University of Birmingham, Birmingham, United Kingdom; the Department of Medical and Molecular Genetics, King's College London, London; the National Institute for Health Research Comprehensive Biomedical Research Centre at Guy's and St. Thomas' National Health Service Foundation Trust and King's College London, London; the Department of Psychiatry, Washington University, St Louis; NeuroSearch A/S; and the Department of Psychiatry, University of Toronto, Toronto.
From the Medical Research Council Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London; the National Institute for Health Research Biomedical Research Centre at South London and Maudsley National Health Service Trust and Institute of Psychiatry, King's College London, London; the Virginia Institute for Psychiatric and Behavioral Genetics of Virginia Commonwealth University, Richmond, Va.; the Center for Biomarker Research and Personalized Medicine, Virginia Commonwealth University, Richmond, Va.; the Department of Pharmacy, Virginia Commonwealth University, Richmond, Va.; Medical Genetics, GlaxoSmithKline, Verona, Italy, and Greenford, United Kingdom; the Medical Research Council Centre for Neuropsychiatric Genetics and Genomics and Neuroscience and Mental Health Research Institute, Cardiff University, Cardiff, United Kingdom; the Department of Psychiatry, Trinity Centre for Health Sciences, Dublin; Barts and the London School of Medicine and Dentistry, London; the Department of Psychiatry, University of Bonn, Bonn, Germany; the Division of Neuroscience and Mental Health, Faculty of Medicine, Imperial College, London; the Max Planck Institute of Psychiatry, Munich, Germany; the Center for Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; the Department of Adult Psychiatry, University Hospital Center and University of Lausanne, Lausanne, Switzerland; the Central Institute of Mental Health, Mannheim, Germany; the Department of Psychiatry, University of Birmingham, Birmingham, United Kingdom; the Department of Medical and Molecular Genetics, King's College London, London; the National Institute for Health Research Comprehensive Biomedical Research Centre at Guy's and St. Thomas' National Health Service Foundation Trust and King's College London, London; the Department of Psychiatry, Washington University, St Louis; NeuroSearch A/S; and the Department of Psychiatry, University of Toronto, Toronto.
From the Medical Research Council Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London; the National Institute for Health Research Biomedical Research Centre at South London and Maudsley National Health Service Trust and Institute of Psychiatry, King's College London, London; the Virginia Institute for Psychiatric and Behavioral Genetics of Virginia Commonwealth University, Richmond, Va.; the Center for Biomarker Research and Personalized Medicine, Virginia Commonwealth University, Richmond, Va.; the Department of Pharmacy, Virginia Commonwealth University, Richmond, Va.; Medical Genetics, GlaxoSmithKline, Verona, Italy, and Greenford, United Kingdom; the Medical Research Council Centre for Neuropsychiatric Genetics and Genomics and Neuroscience and Mental Health Research Institute, Cardiff University, Cardiff, United Kingdom; the Department of Psychiatry, Trinity Centre for Health Sciences, Dublin; Barts and the London School of Medicine and Dentistry, London; the Department of Psychiatry, University of Bonn, Bonn, Germany; the Division of Neuroscience and Mental Health, Faculty of Medicine, Imperial College, London; the Max Planck Institute of Psychiatry, Munich, Germany; the Center for Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; the Department of Adult Psychiatry, University Hospital Center and University of Lausanne, Lausanne, Switzerland; the Central Institute of Mental Health, Mannheim, Germany; the Department of Psychiatry, University of Birmingham, Birmingham, United Kingdom; the Department of Medical and Molecular Genetics, King's College London, London; the National Institute for Health Research Comprehensive Biomedical Research Centre at Guy's and St. Thomas' National Health Service Foundation Trust and King's College London, London; the Department of Psychiatry, Washington University, St Louis; NeuroSearch A/S; and the Department of Psychiatry, University of Toronto, Toronto.
From the Medical Research Council Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London; the National Institute for Health Research Biomedical Research Centre at South London and Maudsley National Health Service Trust and Institute of Psychiatry, King's College London, London; the Virginia Institute for Psychiatric and Behavioral Genetics of Virginia Commonwealth University, Richmond, Va.; the Center for Biomarker Research and Personalized Medicine, Virginia Commonwealth University, Richmond, Va.; the Department of Pharmacy, Virginia Commonwealth University, Richmond, Va.; Medical Genetics, GlaxoSmithKline, Verona, Italy, and Greenford, United Kingdom; the Medical Research Council Centre for Neuropsychiatric Genetics and Genomics and Neuroscience and Mental Health Research Institute, Cardiff University, Cardiff, United Kingdom; the Department of Psychiatry, Trinity Centre for Health Sciences, Dublin; Barts and the London School of Medicine and Dentistry, London; the Department of Psychiatry, University of Bonn, Bonn, Germany; the Division of Neuroscience and Mental Health, Faculty of Medicine, Imperial College, London; the Max Planck Institute of Psychiatry, Munich, Germany; the Center for Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; the Department of Adult Psychiatry, University Hospital Center and University of Lausanne, Lausanne, Switzerland; the Central Institute of Mental Health, Mannheim, Germany; the Department of Psychiatry, University of Birmingham, Birmingham, United Kingdom; the Department of Medical and Molecular Genetics, King's College London, London; the National Institute for Health Research Comprehensive Biomedical Research Centre at Guy's and St. Thomas' National Health Service Foundation Trust and King's College London, London; the Department of Psychiatry, Washington University, St Louis; NeuroSearch A/S; and the Department of Psychiatry, University of Toronto, Toronto.
From the Medical Research Council Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London; the National Institute for Health Research Biomedical Research Centre at South London and Maudsley National Health Service Trust and Institute of Psychiatry, King's College London, London; the Virginia Institute for Psychiatric and Behavioral Genetics of Virginia Commonwealth University, Richmond, Va.; the Center for Biomarker Research and Personalized Medicine, Virginia Commonwealth University, Richmond, Va.; the Department of Pharmacy, Virginia Commonwealth University, Richmond, Va.; Medical Genetics, GlaxoSmithKline, Verona, Italy, and Greenford, United Kingdom; the Medical Research Council Centre for Neuropsychiatric Genetics and Genomics and Neuroscience and Mental Health Research Institute, Cardiff University, Cardiff, United Kingdom; the Department of Psychiatry, Trinity Centre for Health Sciences, Dublin; Barts and the London School of Medicine and Dentistry, London; the Department of Psychiatry, University of Bonn, Bonn, Germany; the Division of Neuroscience and Mental Health, Faculty of Medicine, Imperial College, London; the Max Planck Institute of Psychiatry, Munich, Germany; the Center for Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; the Department of Adult Psychiatry, University Hospital Center and University of Lausanne, Lausanne, Switzerland; the Central Institute of Mental Health, Mannheim, Germany; the Department of Psychiatry, University of Birmingham, Birmingham, United Kingdom; the Department of Medical and Molecular Genetics, King's College London, London; the National Institute for Health Research Comprehensive Biomedical Research Centre at Guy's and St. Thomas' National Health Service Foundation Trust and King's College London, London; the Department of Psychiatry, Washington University, St Louis; NeuroSearch A/S; and the Department of Psychiatry, University of Toronto, Toronto.
From the Medical Research Council Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London; the National Institute for Health Research Biomedical Research Centre at South London and Maudsley National Health Service Trust and Institute of Psychiatry, King's College London, London; the Virginia Institute for Psychiatric and Behavioral Genetics of Virginia Commonwealth University, Richmond, Va.; the Center for Biomarker Research and Personalized Medicine, Virginia Commonwealth University, Richmond, Va.; the Department of Pharmacy, Virginia Commonwealth University, Richmond, Va.; Medical Genetics, GlaxoSmithKline, Verona, Italy, and Greenford, United Kingdom; the Medical Research Council Centre for Neuropsychiatric Genetics and Genomics and Neuroscience and Mental Health Research Institute, Cardiff University, Cardiff, United Kingdom; the Department of Psychiatry, Trinity Centre for Health Sciences, Dublin; Barts and the London School of Medicine and Dentistry, London; the Department of Psychiatry, University of Bonn, Bonn, Germany; the Division of Neuroscience and Mental Health, Faculty of Medicine, Imperial College, London; the Max Planck Institute of Psychiatry, Munich, Germany; the Center for Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; the Department of Adult Psychiatry, University Hospital Center and University of Lausanne, Lausanne, Switzerland; the Central Institute of Mental Health, Mannheim, Germany; the Department of Psychiatry, University of Birmingham, Birmingham, United Kingdom; the Department of Medical and Molecular Genetics, King's College London, London; the National Institute for Health Research Comprehensive Biomedical Research Centre at Guy's and St. Thomas' National Health Service Foundation Trust and King's College London, London; the Department of Psychiatry, Washington University, St Louis; NeuroSearch A/S; and the Department of Psychiatry, University of Toronto, Toronto.
From the Medical Research Council Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London; the National Institute for Health Research Biomedical Research Centre at South London and Maudsley National Health Service Trust and Institute of Psychiatry, King's College London, London; the Virginia Institute for Psychiatric and Behavioral Genetics of Virginia Commonwealth University, Richmond, Va.; the Center for Biomarker Research and Personalized Medicine, Virginia Commonwealth University, Richmond, Va.; the Department of Pharmacy, Virginia Commonwealth University, Richmond, Va.; Medical Genetics, GlaxoSmithKline, Verona, Italy, and Greenford, United Kingdom; the Medical Research Council Centre for Neuropsychiatric Genetics and Genomics and Neuroscience and Mental Health Research Institute, Cardiff University, Cardiff, United Kingdom; the Department of Psychiatry, Trinity Centre for Health Sciences, Dublin; Barts and the London School of Medicine and Dentistry, London; the Department of Psychiatry, University of Bonn, Bonn, Germany; the Division of Neuroscience and Mental Health, Faculty of Medicine, Imperial College, London; the Max Planck Institute of Psychiatry, Munich, Germany; the Center for Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; the Department of Adult Psychiatry, University Hospital Center and University of Lausanne, Lausanne, Switzerland; the Central Institute of Mental Health, Mannheim, Germany; the Department of Psychiatry, University of Birmingham, Birmingham, United Kingdom; the Department of Medical and Molecular Genetics, King's College London, London; the National Institute for Health Research Comprehensive Biomedical Research Centre at Guy's and St. Thomas' National Health Service Foundation Trust and King's College London, London; the Department of Psychiatry, Washington University, St Louis; NeuroSearch A/S; and the Department of Psychiatry, University of Toronto, Toronto.
From the Medical Research Council Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London; the National Institute for Health Research Biomedical Research Centre at South London and Maudsley National Health Service Trust and Institute of Psychiatry, King's College London, London; the Virginia Institute for Psychiatric and Behavioral Genetics of Virginia Commonwealth University, Richmond, Va.; the Center for Biomarker Research and Personalized Medicine, Virginia Commonwealth University, Richmond, Va.; the Department of Pharmacy, Virginia Commonwealth University, Richmond, Va.; Medical Genetics, GlaxoSmithKline, Verona, Italy, and Greenford, United Kingdom; the Medical Research Council Centre for Neuropsychiatric Genetics and Genomics and Neuroscience and Mental Health Research Institute, Cardiff University, Cardiff, United Kingdom; the Department of Psychiatry, Trinity Centre for Health Sciences, Dublin; Barts and the London School of Medicine and Dentistry, London; the Department of Psychiatry, University of Bonn, Bonn, Germany; the Division of Neuroscience and Mental Health, Faculty of Medicine, Imperial College, London; the Max Planck Institute of Psychiatry, Munich, Germany; the Center for Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; the Department of Adult Psychiatry, University Hospital Center and University of Lausanne, Lausanne, Switzerland; the Central Institute of Mental Health, Mannheim, Germany; the Department of Psychiatry, University of Birmingham, Birmingham, United Kingdom; the Department of Medical and Molecular Genetics, King's College London, London; the National Institute for Health Research Comprehensive Biomedical Research Centre at Guy's and St. Thomas' National Health Service Foundation Trust and King's College London, London; the Department of Psychiatry, Washington University, St Louis; NeuroSearch A/S; and the Department of Psychiatry, University of Toronto, Toronto.
From the Medical Research Council Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London; the National Institute for Health Research Biomedical Research Centre at South London and Maudsley National Health Service Trust and Institute of Psychiatry, King's College London, London; the Virginia Institute for Psychiatric and Behavioral Genetics of Virginia Commonwealth University, Richmond, Va.; the Center for Biomarker Research and Personalized Medicine, Virginia Commonwealth University, Richmond, Va.; the Department of Pharmacy, Virginia Commonwealth University, Richmond, Va.; Medical Genetics, GlaxoSmithKline, Verona, Italy, and Greenford, United Kingdom; the Medical Research Council Centre for Neuropsychiatric Genetics and Genomics and Neuroscience and Mental Health Research Institute, Cardiff University, Cardiff, United Kingdom; the Department of Psychiatry, Trinity Centre for Health Sciences, Dublin; Barts and the London School of Medicine and Dentistry, London; the Department of Psychiatry, University of Bonn, Bonn, Germany; the Division of Neuroscience and Mental Health, Faculty of Medicine, Imperial College, London; the Max Planck Institute of Psychiatry, Munich, Germany; the Center for Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; the Department of Adult Psychiatry, University Hospital Center and University of Lausanne, Lausanne, Switzerland; the Central Institute of Mental Health, Mannheim, Germany; the Department of Psychiatry, University of Birmingham, Birmingham, United Kingdom; the Department of Medical and Molecular Genetics, King's College London, London; the National Institute for Health Research Comprehensive Biomedical Research Centre at Guy's and St. Thomas' National Health Service Foundation Trust and King's College London, London; the Department of Psychiatry, Washington University, St Louis; NeuroSearch A/S; and the Department of Psychiatry, University of Toronto, Toronto.
From the Medical Research Council Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London; the National Institute for Health Research Biomedical Research Centre at South London and Maudsley National Health Service Trust and Institute of Psychiatry, King's College London, London; the Virginia Institute for Psychiatric and Behavioral Genetics of Virginia Commonwealth University, Richmond, Va.; the Center for Biomarker Research and Personalized Medicine, Virginia Commonwealth University, Richmond, Va.; the Department of Pharmacy, Virginia Commonwealth University, Richmond, Va.; Medical Genetics, GlaxoSmithKline, Verona, Italy, and Greenford, United Kingdom; the Medical Research Council Centre for Neuropsychiatric Genetics and Genomics and Neuroscience and Mental Health Research Institute, Cardiff University, Cardiff, United Kingdom; the Department of Psychiatry, Trinity Centre for Health Sciences, Dublin; Barts and the London School of Medicine and Dentistry, London; the Department of Psychiatry, University of Bonn, Bonn, Germany; the Division of Neuroscience and Mental Health, Faculty of Medicine, Imperial College, London; the Max Planck Institute of Psychiatry, Munich, Germany; the Center for Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; the Department of Adult Psychiatry, University Hospital Center and University of Lausanne, Lausanne, Switzerland; the Central Institute of Mental Health, Mannheim, Germany; the Department of Psychiatry, University of Birmingham, Birmingham, United Kingdom; the Department of Medical and Molecular Genetics, King's College London, London; the National Institute for Health Research Comprehensive Biomedical Research Centre at Guy's and St. Thomas' National Health Service Foundation Trust and King's College London, London; the Department of Psychiatry, Washington University, St Louis; NeuroSearch A/S; and the Department of Psychiatry, University of Toronto, Toronto.
From the Medical Research Council Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London; the National Institute for Health Research Biomedical Research Centre at South London and Maudsley National Health Service Trust and Institute of Psychiatry, King's College London, London; the Virginia Institute for Psychiatric and Behavioral Genetics of Virginia Commonwealth University, Richmond, Va.; the Center for Biomarker Research and Personalized Medicine, Virginia Commonwealth University, Richmond, Va.; the Department of Pharmacy, Virginia Commonwealth University, Richmond, Va.; Medical Genetics, GlaxoSmithKline, Verona, Italy, and Greenford, United Kingdom; the Medical Research Council Centre for Neuropsychiatric Genetics and Genomics and Neuroscience and Mental Health Research Institute, Cardiff University, Cardiff, United Kingdom; the Department of Psychiatry, Trinity Centre for Health Sciences, Dublin; Barts and the London School of Medicine and Dentistry, London; the Department of Psychiatry, University of Bonn, Bonn, Germany; the Division of Neuroscience and Mental Health, Faculty of Medicine, Imperial College, London; the Max Planck Institute of Psychiatry, Munich, Germany; the Center for Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; the Department of Adult Psychiatry, University Hospital Center and University of Lausanne, Lausanne, Switzerland; the Central Institute of Mental Health, Mannheim, Germany; the Department of Psychiatry, University of Birmingham, Birmingham, United Kingdom; the Department of Medical and Molecular Genetics, King's College London, London; the National Institute for Health Research Comprehensive Biomedical Research Centre at Guy's and St. Thomas' National Health Service Foundation Trust and King's College London, London; the Department of Psychiatry, Washington University, St Louis; NeuroSearch A/S; and the Department of Psychiatry, University of Toronto, Toronto.
From the Medical Research Council Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London; the National Institute for Health Research Biomedical Research Centre at South London and Maudsley National Health Service Trust and Institute of Psychiatry, King's College London, London; the Virginia Institute for Psychiatric and Behavioral Genetics of Virginia Commonwealth University, Richmond, Va.; the Center for Biomarker Research and Personalized Medicine, Virginia Commonwealth University, Richmond, Va.; the Department of Pharmacy, Virginia Commonwealth University, Richmond, Va.; Medical Genetics, GlaxoSmithKline, Verona, Italy, and Greenford, United Kingdom; the Medical Research Council Centre for Neuropsychiatric Genetics and Genomics and Neuroscience and Mental Health Research Institute, Cardiff University, Cardiff, United Kingdom; the Department of Psychiatry, Trinity Centre for Health Sciences, Dublin; Barts and the London School of Medicine and Dentistry, London; the Department of Psychiatry, University of Bonn, Bonn, Germany; the Division of Neuroscience and Mental Health, Faculty of Medicine, Imperial College, London; the Max Planck Institute of Psychiatry, Munich, Germany; the Center for Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; the Department of Adult Psychiatry, University Hospital Center and University of Lausanne, Lausanne, Switzerland; the Central Institute of Mental Health, Mannheim, Germany; the Department of Psychiatry, University of Birmingham, Birmingham, United Kingdom; the Department of Medical and Molecular Genetics, King's College London, London; the National Institute for Health Research Comprehensive Biomedical Research Centre at Guy's and St. Thomas' National Health Service Foundation Trust and King's College London, London; the Department of Psychiatry, Washington University, St Louis; NeuroSearch A/S; and the Department of Psychiatry, University of Toronto, Toronto.
From the Medical Research Council Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London; the National Institute for Health Research Biomedical Research Centre at South London and Maudsley National Health Service Trust and Institute of Psychiatry, King's College London, London; the Virginia Institute for Psychiatric and Behavioral Genetics of Virginia Commonwealth University, Richmond, Va.; the Center for Biomarker Research and Personalized Medicine, Virginia Commonwealth University, Richmond, Va.; the Department of Pharmacy, Virginia Commonwealth University, Richmond, Va.; Medical Genetics, GlaxoSmithKline, Verona, Italy, and Greenford, United Kingdom; the Medical Research Council Centre for Neuropsychiatric Genetics and Genomics and Neuroscience and Mental Health Research Institute, Cardiff University, Cardiff, United Kingdom; the Department of Psychiatry, Trinity Centre for Health Sciences, Dublin; Barts and the London School of Medicine and Dentistry, London; the Department of Psychiatry, University of Bonn, Bonn, Germany; the Division of Neuroscience and Mental Health, Faculty of Medicine, Imperial College, London; the Max Planck Institute of Psychiatry, Munich, Germany; the Center for Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; the Department of Adult Psychiatry, University Hospital Center and University of Lausanne, Lausanne, Switzerland; the Central Institute of Mental Health, Mannheim, Germany; the Department of Psychiatry, University of Birmingham, Birmingham, United Kingdom; the Department of Medical and Molecular Genetics, King's College London, London; the National Institute for Health Research Comprehensive Biomedical Research Centre at Guy's and St. Thomas' National Health Service Foundation Trust and King's College London, London; the Department of Psychiatry, Washington University, St Louis; NeuroSearch A/S; and the Department of Psychiatry, University of Toronto, Toronto.
From the Medical Research Council Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London; the National Institute for Health Research Biomedical Research Centre at South London and Maudsley National Health Service Trust and Institute of Psychiatry, King's College London, London; the Virginia Institute for Psychiatric and Behavioral Genetics of Virginia Commonwealth University, Richmond, Va.; the Center for Biomarker Research and Personalized Medicine, Virginia Commonwealth University, Richmond, Va.; the Department of Pharmacy, Virginia Commonwealth University, Richmond, Va.; Medical Genetics, GlaxoSmithKline, Verona, Italy, and Greenford, United Kingdom; the Medical Research Council Centre for Neuropsychiatric Genetics and Genomics and Neuroscience and Mental Health Research Institute, Cardiff University, Cardiff, United Kingdom; the Department of Psychiatry, Trinity Centre for Health Sciences, Dublin; Barts and the London School of Medicine and Dentistry, London; the Department of Psychiatry, University of Bonn, Bonn, Germany; the Division of Neuroscience and Mental Health, Faculty of Medicine, Imperial College, London; the Max Planck Institute of Psychiatry, Munich, Germany; the Center for Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; the Department of Adult Psychiatry, University Hospital Center and University of Lausanne, Lausanne, Switzerland; the Central Institute of Mental Health, Mannheim, Germany; the Department of Psychiatry, University of Birmingham, Birmingham, United Kingdom; the Department of Medical and Molecular Genetics, King's College London, London; the National Institute for Health Research Comprehensive Biomedical Research Centre at Guy's and St. Thomas' National Health Service Foundation Trust and King's College London, London; the Department of Psychiatry, Washington University, St Louis; NeuroSearch A/S; and the Department of Psychiatry, University of Toronto, Toronto.
From the Medical Research Council Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London; the National Institute for Health Research Biomedical Research Centre at South London and Maudsley National Health Service Trust and Institute of Psychiatry, King's College London, London; the Virginia Institute for Psychiatric and Behavioral Genetics of Virginia Commonwealth University, Richmond, Va.; the Center for Biomarker Research and Personalized Medicine, Virginia Commonwealth University, Richmond, Va.; the Department of Pharmacy, Virginia Commonwealth University, Richmond, Va.; Medical Genetics, GlaxoSmithKline, Verona, Italy, and Greenford, United Kingdom; the Medical Research Council Centre for Neuropsychiatric Genetics and Genomics and Neuroscience and Mental Health Research Institute, Cardiff University, Cardiff, United Kingdom; the Department of Psychiatry, Trinity Centre for Health Sciences, Dublin; Barts and the London School of Medicine and Dentistry, London; the Department of Psychiatry, University of Bonn, Bonn, Germany; the Division of Neuroscience and Mental Health, Faculty of Medicine, Imperial College, London; the Max Planck Institute of Psychiatry, Munich, Germany; the Center for Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; the Department of Adult Psychiatry, University Hospital Center and University of Lausanne, Lausanne, Switzerland; the Central Institute of Mental Health, Mannheim, Germany; the Department of Psychiatry, University of Birmingham, Birmingham, United Kingdom; the Department of Medical and Molecular Genetics, King's College London, London; the National Institute for Health Research Comprehensive Biomedical Research Centre at Guy's and St. Thomas' National Health Service Foundation Trust and King's College London, London; the Department of Psychiatry, Washington University, St Louis; NeuroSearch A/S; and the Department of Psychiatry, University of Toronto, Toronto.
From the Medical Research Council Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London; the National Institute for Health Research Biomedical Research Centre at South London and Maudsley National Health Service Trust and Institute of Psychiatry, King's College London, London; the Virginia Institute for Psychiatric and Behavioral Genetics of Virginia Commonwealth University, Richmond, Va.; the Center for Biomarker Research and Personalized Medicine, Virginia Commonwealth University, Richmond, Va.; the Department of Pharmacy, Virginia Commonwealth University, Richmond, Va.; Medical Genetics, GlaxoSmithKline, Verona, Italy, and Greenford, United Kingdom; the Medical Research Council Centre for Neuropsychiatric Genetics and Genomics and Neuroscience and Mental Health Research Institute, Cardiff University, Cardiff, United Kingdom; the Department of Psychiatry, Trinity Centre for Health Sciences, Dublin; Barts and the London School of Medicine and Dentistry, London; the Department of Psychiatry, University of Bonn, Bonn, Germany; the Division of Neuroscience and Mental Health, Faculty of Medicine, Imperial College, London; the Max Planck Institute of Psychiatry, Munich, Germany; the Center for Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; the Department of Adult Psychiatry, University Hospital Center and University of Lausanne, Lausanne, Switzerland; the Central Institute of Mental Health, Mannheim, Germany; the Department of Psychiatry, University of Birmingham, Birmingham, United Kingdom; the Department of Medical and Molecular Genetics, King's College London, London; the National Institute for Health Research Comprehensive Biomedical Research Centre at Guy's and St. Thomas' National Health Service Foundation Trust and King's College London, London; the Department of Psychiatry, Washington University, St Louis; NeuroSearch A/S; and the Department of Psychiatry, University of Toronto, Toronto.
From the Medical Research Council Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London; the National Institute for Health Research Biomedical Research Centre at South London and Maudsley National Health Service Trust and Institute of Psychiatry, King's College London, London; the Virginia Institute for Psychiatric and Behavioral Genetics of Virginia Commonwealth University, Richmond, Va.; the Center for Biomarker Research and Personalized Medicine, Virginia Commonwealth University, Richmond, Va.; the Department of Pharmacy, Virginia Commonwealth University, Richmond, Va.; Medical Genetics, GlaxoSmithKline, Verona, Italy, and Greenford, United Kingdom; the Medical Research Council Centre for Neuropsychiatric Genetics and Genomics and Neuroscience and Mental Health Research Institute, Cardiff University, Cardiff, United Kingdom; the Department of Psychiatry, Trinity Centre for Health Sciences, Dublin; Barts and the London School of Medicine and Dentistry, London; the Department of Psychiatry, University of Bonn, Bonn, Germany; the Division of Neuroscience and Mental Health, Faculty of Medicine, Imperial College, London; the Max Planck Institute of Psychiatry, Munich, Germany; the Center for Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; the Department of Adult Psychiatry, University Hospital Center and University of Lausanne, Lausanne, Switzerland; the Central Institute of Mental Health, Mannheim, Germany; the Department of Psychiatry, University of Birmingham, Birmingham, United Kingdom; the Department of Medical and Molecular Genetics, King's College London, London; the National Institute for Health Research Comprehensive Biomedical Research Centre at Guy's and St. Thomas' National Health Service Foundation Trust and King's College London, London; the Department of Psychiatry, Washington University, St Louis; NeuroSearch A/S; and the Department of Psychiatry, University of Toronto, Toronto.
From the Medical Research Council Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London; the National Institute for Health Research Biomedical Research Centre at South London and Maudsley National Health Service Trust and Institute of Psychiatry, King's College London, London; the Virginia Institute for Psychiatric and Behavioral Genetics of Virginia Commonwealth University, Richmond, Va.; the Center for Biomarker Research and Personalized Medicine, Virginia Commonwealth University, Richmond, Va.; the Department of Pharmacy, Virginia Commonwealth University, Richmond, Va.; Medical Genetics, GlaxoSmithKline, Verona, Italy, and Greenford, United Kingdom; the Medical Research Council Centre for Neuropsychiatric Genetics and Genomics and Neuroscience and Mental Health Research Institute, Cardiff University, Cardiff, United Kingdom; the Department of Psychiatry, Trinity Centre for Health Sciences, Dublin; Barts and the London School of Medicine and Dentistry, London; the Department of Psychiatry, University of Bonn, Bonn, Germany; the Division of Neuroscience and Mental Health, Faculty of Medicine, Imperial College, London; the Max Planck Institute of Psychiatry, Munich, Germany; the Center for Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; the Department of Adult Psychiatry, University Hospital Center and University of Lausanne, Lausanne, Switzerland; the Central Institute of Mental Health, Mannheim, Germany; the Department of Psychiatry, University of Birmingham, Birmingham, United Kingdom; the Department of Medical and Molecular Genetics, King's College London, London; the National Institute for Health Research Comprehensive Biomedical Research Centre at Guy's and St. Thomas' National Health Service Foundation Trust and King's College London, London; the Department of Psychiatry, Washington University, St Louis; NeuroSearch A/S; and the Department of Psychiatry, University of Toronto, Toronto.
From the Medical Research Council Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London; the National Institute for Health Research Biomedical Research Centre at South London and Maudsley National Health Service Trust and Institute of Psychiatry, King's College London, London; the Virginia Institute for Psychiatric and Behavioral Genetics of Virginia Commonwealth University, Richmond, Va.; the Center for Biomarker Research and Personalized Medicine, Virginia Commonwealth University, Richmond, Va.; the Department of Pharmacy, Virginia Commonwealth University, Richmond, Va.; Medical Genetics, GlaxoSmithKline, Verona, Italy, and Greenford, United Kingdom; the Medical Research Council Centre for Neuropsychiatric Genetics and Genomics and Neuroscience and Mental Health Research Institute, Cardiff University, Cardiff, United Kingdom; the Department of Psychiatry, Trinity Centre for Health Sciences, Dublin; Barts and the London School of Medicine and Dentistry, London; the Department of Psychiatry, University of Bonn, Bonn, Germany; the Division of Neuroscience and Mental Health, Faculty of Medicine, Imperial College, London; the Max Planck Institute of Psychiatry, Munich, Germany; the Center for Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; the Department of Adult Psychiatry, University Hospital Center and University of Lausanne, Lausanne, Switzerland; the Central Institute of Mental Health, Mannheim, Germany; the Department of Psychiatry, University of Birmingham, Birmingham, United Kingdom; the Department of Medical and Molecular Genetics, King's College London, London; the National Institute for Health Research Comprehensive Biomedical Research Centre at Guy's and St. Thomas' National Health Service Foundation Trust and King's College London, London; the Department of Psychiatry, Washington University, St Louis; NeuroSearch A/S; and the Department of Psychiatry, University of Toronto, Toronto.
From the Medical Research Council Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London; the National Institute for Health Research Biomedical Research Centre at South London and Maudsley National Health Service Trust and Institute of Psychiatry, King's College London, London; the Virginia Institute for Psychiatric and Behavioral Genetics of Virginia Commonwealth University, Richmond, Va.; the Center for Biomarker Research and Personalized Medicine, Virginia Commonwealth University, Richmond, Va.; the Department of Pharmacy, Virginia Commonwealth University, Richmond, Va.; Medical Genetics, GlaxoSmithKline, Verona, Italy, and Greenford, United Kingdom; the Medical Research Council Centre for Neuropsychiatric Genetics and Genomics and Neuroscience and Mental Health Research Institute, Cardiff University, Cardiff, United Kingdom; the Department of Psychiatry, Trinity Centre for Health Sciences, Dublin; Barts and the London School of Medicine and Dentistry, London; the Department of Psychiatry, University of Bonn, Bonn, Germany; the Division of Neuroscience and Mental Health, Faculty of Medicine, Imperial College, London; the Max Planck Institute of Psychiatry, Munich, Germany; the Center for Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; the Department of Adult Psychiatry, University Hospital Center and University of Lausanne, Lausanne, Switzerland; the Central Institute of Mental Health, Mannheim, Germany; the Department of Psychiatry, University of Birmingham, Birmingham, United Kingdom; the Department of Medical and Molecular Genetics, King's College London, London; the National Institute for Health Research Comprehensive Biomedical Research Centre at Guy's and St. Thomas' National Health Service Foundation Trust and King's College London, London; the Department of Psychiatry, Washington University, St Louis; NeuroSearch A/S; and the Department of Psychiatry, University of Toronto, Toronto.
Supplemental Material
ajp_168_08_840_01.pdf (338 KB)